Skip to content

Clinical trials

Phase 1/2 Urinary Bladder Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 1/2 Country / region: Australia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20191
20201
20213
20223
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Active, not recruiting3
Terminated3
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
AstraZeneca1
Aulos Bioscience, Inc.1
Basilea Pharmaceutica1
Fusion Pharmaceuticals Inc.1
Medicenna Therapeutics, Inc.1
Merck Sharp & Dohme LLC1
Second Life Therapeutics1
Tyra Biosciences, Inc1
Xennials Therapeutics Australia Pty Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms12
Stomach Neoplasms6
Ovarian Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Colorectal Neoplasms4
Melanoma4
Neoplasm Metastasis4
Squamous Cell Carcinoma of Head and Neck4
Breast Neoplasms3
Carcinoma, Transitional Cell3

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.